Search

Author/Creator Moss, Rebecca A

2. Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study. Issue 9 (September 2017)

Authors:
Overman, Michael J; McDermott, Ray; Leach, Joseph L; Lonardi, Sara; Lenz, Heinz-Josef; Morse, Michael A; Desai, Jayesh; Hill, Andrew; Axelson, Michael; Moss, Rebecca A; Goldberg, Monica V; Cao, Z Alexander; Ledeine, Jean-Marie; Maglinte, Gregory A; Kopetz, Scott; André, Thierry
Journal:
Lancet oncology
Issue:
Volume 18:Issue 9(2017:Sep.)
Page Start:
1182
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Society for Immunotherapy of Cancer (SITC) consensus definitions for resistance to combinations of immune checkpoint inhibitors. Issue 3 (14th March 2023)

Authors:
Kluger, Harriet; Barrett, J Carl; Gainor, Justin F; Hamid, Omid; Hurwitz, Michael; LaVallee, Theresa; Moss, Rebecca A; Zappasodi, Roberta; Sullivan, Ryan J; Tawbi, Hussein; Sharon, Elad
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 11:Issue 3(2023)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗